These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1187 related articles for article (PubMed ID: 32493482)
81. Leucosceptoside A from Devil's Claw Modulates Psoriasis-like Inflammation via Suppression of the PI3K/AKT Signaling Pathway in Keratinocytes. Koycheva IK; Mihaylova LV; Todorova MN; Balcheva-Sivenova ZP; Alipieva K; Ferrante C; Orlando G; Georgiev MI Molecules; 2021 Nov; 26(22):. PubMed ID: 34834106 [TBL] [Abstract][Full Text] [Related]
82. MAD ointment ameliorates Imiquimod-induced psoriasiform dermatitis by inhibiting the IL-23/IL-17 axis in mice. OuYang Q; Pan Y; Luo H; Xuan C; Liu J; Liu J Int Immunopharmacol; 2016 Oct; 39():369-376. PubMed ID: 27540765 [TBL] [Abstract][Full Text] [Related]
83. 310 nm UV-LEDs attenuate imiquimod-induced psoriasis-like skin lesions in C57BL/6 mice and inhibit IL-22-induced STAT3 expression in HaCaT cells. Kwon TR; Lee SE; Kim JH; Na Jang Y; Kim SY; Mun SK; Kim CW; Na J; Kim BJ Photochem Photobiol Sci; 2020 Aug; 19(8):1009-1021. PubMed ID: 32584352 [TBL] [Abstract][Full Text] [Related]
84. Increased βTrCP are associated with imiquimod-induced psoriasis-like skin inflammation in mice via NF-κB signaling pathway. Li R; Wang J; Wang X; Zhou J; Wang M; Ma H; Xiao S Gene; 2016 Oct; 592(1):164-171. PubMed ID: 27476970 [TBL] [Abstract][Full Text] [Related]
85. [Expressions of survivin, PI3K and AKT in keratinocytes in skin lesions and their pathogenic role in psoriasis vulgaris]. Wang H; Ran LW; Hui K; Wang XY; Zheng Y Nan Fang Yi Ke Da Xue Xue Bao; 2017 Nov; 37(11):1512-1516. PubMed ID: 29180333 [TBL] [Abstract][Full Text] [Related]
86. Taxifolin inhibits keratinocyte proliferation and ameliorates imiquimod-induced psoriasis-like mouse model via regulating cytoplasmic phospholipase A2 and PPAR-γ pathway. Di T; Zhai C; Zhao J; Wang Y; Chen Z; Li P Int Immunopharmacol; 2021 Oct; 99():107900. PubMed ID: 34233233 [TBL] [Abstract][Full Text] [Related]
87. Synergistic phototoxic effects of glycolic acid in a human keratinocyte cell line (HaCaT). Lai WW; Hsiao YP; Chung JG; Wei YH; Cheng YW; Yang JH J Dermatol Sci; 2011 Dec; 64(3):191-8. PubMed ID: 21993420 [TBL] [Abstract][Full Text] [Related]
88. Imiquimod-induced psoriasis-like inflammation in differentiated Human keratinocytes: Its evaluation using curcumin. Varma SR; Sivaprakasam TO; Mishra A; Prabhu S; M R; P R Eur J Pharmacol; 2017 Oct; 813():33-41. PubMed ID: 28736282 [TBL] [Abstract][Full Text] [Related]
89. Losartan ointment attenuates imiquimod-induced psoriasis-like inflammation. Shokrian Zeini M; Haddadi NS; Shayan M; Shokrian Zeini M; Kazemi K; Solaimanian S; Abdollahifar MA; Hedayatyanfard K; Dehpour AR Int Immunopharmacol; 2021 Nov; 100():108160. PubMed ID: 34583123 [TBL] [Abstract][Full Text] [Related]
90. Piperlongumine regulates epigenetic modulation and alleviates psoriasis-like skin inflammation via inhibition of hyperproliferation and inflammation. Thatikonda S; Pooladanda V; Sigalapalli DK; Godugu C Cell Death Dis; 2020 Jan; 11(1):21. PubMed ID: 31924750 [TBL] [Abstract][Full Text] [Related]
91. The Impact of Proinflammatory Cytokines and Imiquimod on GLUT1 in HaCaT Keratinocytes - a Potential Anti-Psoriatic Therapeutic Target? Makuch S; Kupczyk P; Makarec A; Chodaczek G; Ziółkowski P; Woźniak M Cell Physiol Biochem; 2023 Mar; 57(2):54-62. PubMed ID: 36945896 [TBL] [Abstract][Full Text] [Related]
92. Effect of γ-secretase inhibitor on Th17 cell differentiation and function of mouse psoriasis-like skin inflammation. Ma L; Xue H; Qi R; Wang Y; Yuan L J Transl Med; 2018 Mar; 16(1):59. PubMed ID: 29523162 [TBL] [Abstract][Full Text] [Related]
93. 18β-Glycyrrhetinic acid suppresses TNF-α induced matrix metalloproteinase-9 and vascular endothelial growth factor by suppressing the Akt-dependent NF-κB pathway. Jayasooriya RG; Dilshara MG; Park SR; Choi YH; Hyun JW; Chang WY; Kim GY Toxicol In Vitro; 2014 Aug; 28(5):751-8. PubMed ID: 24613819 [TBL] [Abstract][Full Text] [Related]
94. Qingxiong Ointment and its Active Ingredient, Shikonin Treat Psoriasis through HIF-1 Signaling Pathway. Zhang B; Yan G; Li F; Tang Y; Xu G; Zhang Y; Ze K Curr Pharm Des; 2024; 30(24):1927-1938. PubMed ID: 38835124 [TBL] [Abstract][Full Text] [Related]
95. PI3K/AKT/mTOR activation and autophagy inhibition plays a key role in increased cholesterol during IL-17A mediated inflammatory response in psoriasis. Varshney P; Saini N Biochim Biophys Acta Mol Basis Dis; 2018 May; 1864(5 Pt A):1795-1803. PubMed ID: 29432814 [TBL] [Abstract][Full Text] [Related]
96. MiR-223 regulates proliferation and apoptosis of IL-22-stimulated HaCat human keratinocyte cell lines via the PTEN/Akt pathway. Wang R; Wang FF; Cao HW; Yang JY Life Sci; 2019 Aug; 230():28-34. PubMed ID: 31108094 [TBL] [Abstract][Full Text] [Related]
97. Overexpression of Wilms' tumor 1 in skin lesions of psoriasis is associated with abnormal proliferation and apoptosis of keratinocytes. Wu R; Liao Y; Shen W; Liu Y; Zhang J; Zheng M; Chen G; Su Y; Zhao M; Lu Q Mol Med Rep; 2018 Oct; 18(4):3973-3982. PubMed ID: 30132523 [TBL] [Abstract][Full Text] [Related]
98. Resolvin D1 attenuates imiquimod-induced mice psoriasiform dermatitis through MAPKs and NF-κB pathways. Xu J; Duan X; Hu F; Poorun D; Liu X; Wang X; Zhang S; Gan L; He M; Zhu K; Ming Z; Chen H J Dermatol Sci; 2018 Feb; 89(2):127-135. PubMed ID: 29137840 [TBL] [Abstract][Full Text] [Related]
99. Acetyl-11-keto-β-boswellic acid inhibits the secretion of cytokines by dendritic cells via the TLR7/8 pathway in an imiquimod-induced psoriasis mouse model and in vitro. Wang MX; Zhao JX; Meng YJ; Di TT; Xu XL; Xie XJ; Lin Y; Zhang L; Wang N; Li P; Wang Y Life Sci; 2018 Aug; 207():90-104. PubMed ID: 29859222 [TBL] [Abstract][Full Text] [Related]
100. Dendrobium officinale Polysaccharide (DOP) inhibits cell hyperproliferation, inflammation and oxidative stress to improve keratinocyte psoriasis-like state. Zeng B; Yan Y; Zhang Y; Wang C; Huang W; Zhong X; Chen Z; Xie M; Yang Z Adv Med Sci; 2024 Mar; 69(1):167-175. PubMed ID: 38521458 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]